Abstract
Introduction: A large open-label safety study of daxibotulinumtoxina for Injection (DAXI) assessed safety and efficacy with longer-term use and across successive glabellar lines (GL) treatment cycles.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
